Home/Filings/4/0001209191-23-055744
4//SEC Filing

Wadhane Jitendra 4

Accession 0001209191-23-055744

CIK 0001782223other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 4:16 PM ET

Size

4.8 KB

Accession

0001209191-23-055744

Insider Transaction Report

Form 4
Period: 2023-11-15
Wadhane Jitendra
SVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2023-11-15+40,000266,937 total
Footnotes (1)
  • [F1]Represents restricted stock units that vest in full on November 14, 2024, subject to the Reporting Person's continued employment through the vesting date.

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001941706

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:16 PM ET
Size
4.8 KB